enzalutamide – Page 2 – PROSTATE WARRIORS – The latest news about prostate cancer

Tag Archive for: enzalutamide

Trial to Test If Intermittent Fasting Can Boost Prostate Cancer Treatment Efficacy

August 13, 2025/in Clinical Trial, Localized, Metastatic, Phase 1, Phase 2/by Max

Phase Ib/II Study of TYK-00540 Combined With Enzalutamide in mCRPC

August 8, 2025/in Clinical Trial, Metastatic, Phase 1, Phase 2/by Max

LYA914: A Novel Oral PROTAC Targeting Androgen Receptor Variants in Prostate Cancer

July 30, 2025/in Preclinical Research, PROTACs/by Max

Triplet therapy shows strongest survival benefit in mHSPC with visceral disease

July 14, 2025/in Review/by Max

Real-World Studies Suggest Survival Advantage with Apalutamide in mCSPC Treatment

June 20, 2025/in Retrospective studies/by Max

Phase 1/2 Trial: Targeting Resistance With SX-682 And Apalutamide or Enzalutamide

June 18, 2025/in Clinical Trial, Metastatic, Phase 1, Phase 2/by Max

TALAPRO-2 Trial: Final Results Update For HRR Mutations (BRCA, ATM,…)

May 26, 2025/in Clinical Trial, Metastatic, Phase 3/by Max

Phase 3 ENZAMET Trial: Follow-up Data After 8 Years

May 23, 2025/in Clinical Trial, Metastatic, Phase 3/by Max

TALAPRO-2 Trial: Final OS Analisys Confirms Talazoparib + Enzalutamide Effectiveness in mCRPC

May 22, 2025/in Clinical Trial, Metastatic, Phase 3/by Max

Pembrolizumab Plus Enzalutamide Therapy Shows No Benefit in Metastatic Castration-Resistant Prostate Cancer Trial

May 21, 2025/in Clinical Trial, Metastatic, Phase 3/by Max